Glasgow, UK, 10th of May 2010 — ClinTec International, the Global Clinical Research Organisation, has been awarded Women Business Enterprise (WBE) certified status by WEConnect Europe - a not-for-profit organisation, led by corporate members, that is opening doors to new supply chains for businesses in which women executives hold at least 51 per cent share of ownership.
WEConnect certified status is yet further evidence of ClinTec International’s solid performance and the standing of its President, Founder & CEO, Dr Rabinder Buttar. WBE is awarded after a rigorous certification process – including a specific focus on corporate financials.
Development of a diversity agenda at ClinTec International is very much a current focus, which goes in line with conduct of global projects, cross-border client engagements and an internationally diverse workforce. Certification from WEConnect Europe is in line with this initiative and recognition the important role that Women have to play in the management of modern organizations.
In addition, WEConnect Europe will facilitate ClinTec in building and enhancing a strong network of contacts with other certified companies, forge partnerships with clients who have a diversity agenda, and generate business-to-business tendering opportunities.
ClinTec International’s CEO, Dr Rabinder Buttar commenting on the landmark, said: “This certification as a women owned enterprise will further strengthen prospects for securing US and European based contracts from procurement specialists at the world’s largest pharmaceutical organisations. Over the last 13 years, as a women owned enterprise, ClinTec has performed exceptionally well establishing itself in over 40 countries worldwide. ClinTec is committed to meeting the needs of the pharmaceutical industry by providing high quality clinical research services in a fast and flexible manner in all major and emerging markets. As we continue to grow our business, in the increasingly competitive CRO space, we feel it is important to continue our efforts in building a diverse and interesting place to work independent of one’s background or gender.”
About ClinTec International
ClinTec International is a global contract clinical research organisation, established in 1997 by Dr Rabinder Buttar, the company’s President and CEO. ClinTec International has a presence in 40 developed and emerging countries, covering Western Europe, Central & Eastern Europe, the Middle East and North Africa, Central and South Africa, Latin America, India and the US.
In addition to ClinTec International’s vast expertise in oncology, the organisation has also conducted over 250 clinical trials in other therapeutic areas including anti-infectives, cardiology, dermatology, gastroenterology, neurology, respiratory medicine and rheumatology. ClinTec International excels in conducting clinical studies in diverse geographical locations, supported by a team of world-class project managers and clinical research associates. ClinTec International’s „fast, flexible and focused? approach to clinical research ensures an added advantage to the drug development process. The organisations range of services includes Clinical Monitoring and Project Management, Regulatory Affairs, Medical Writing, Data Management and Biostatistics, Global Clinical Resourcing, Quality Assurance, Drug Development Consultancy and Clinical Training courses.
